• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
An analysis of the remission phase in type 1 diabetes within a multiethnic Brazilian sample.巴西多民族样本中1型糖尿病缓解期的分析。
J Pediatr (Rio J). 2025 Mar-Apr;101(2):167-171. doi: 10.1016/j.jped.2024.09.005. Epub 2024 Nov 4.
2
Partial clinical remission in type 1 diabetes: a comparison of the accuracy of total daily dose of insulin of <0.3 units/kg/day to the gold standard insulin-dose adjusted hemoglobin A1c of ≤9 for the detection of partial clinical remission.1型糖尿病的部分临床缓解:比较每日胰岛素总剂量<0.3单位/千克/天与检测部分临床缓解的金标准即胰岛素剂量调整糖化血红蛋白≤9%的准确性。
J Pediatr Endocrinol Metab. 2017 Aug 28;30(8):823-830. doi: 10.1515/jpem-2017-0019.
3
Partial remission in type 1 diabetes and associated factors: Analysis based on the insulin dose-adjusted hemoglobin A1c in children and adolescents from a regional diabetes center, Auckland, New Zealand.1 型糖尿病的部分缓解及其相关因素:基于新西兰奥克兰地区糖尿病中心儿童和青少年的胰岛素剂量调整血红蛋白 A1c 的分析。
Pediatr Diabetes. 2019 Nov;20(7):892-900. doi: 10.1111/pedi.12881. Epub 2019 Jul 4.
4
Factors contributing to partial remission in type 1 diabetes: analysis based on the insulin dose-adjusted HbA1c in 3657 children and adolescents from Germany and Austria.1型糖尿病部分缓解的相关因素:基于德国和奥地利3657名儿童及青少年胰岛素剂量调整后的糖化血红蛋白分析
Pediatr Diabetes. 2017 Sep;18(6):428-434. doi: 10.1111/pedi.12413. Epub 2016 Jul 15.
5
Partial remission in children and adolescents with type 1 diabetes: an analysis based on the insulin dose-adjusted hemoglobin A1c.1型糖尿病儿童和青少年的部分缓解:基于胰岛素剂量调整糖化血红蛋白的分析
J Pediatr Endocrinol Metab. 2021 Jul 19;34(10):1311-1317. doi: 10.1515/jpem-2021-0048. Print 2021 Oct 26.
6
Partial remission definition: validation based on the insulin dose-adjusted HbA1c (IDAA1C) in 129 Danish children with new-onset type 1 diabetes.部分缓解的定义:基于胰岛素剂量调整后的糖化血红蛋白(IDAA1C)对129名丹麦新发1型糖尿病儿童进行验证。
Pediatr Diabetes. 2014 Nov;15(7):469-76. doi: 10.1111/pedi.12208.
7
Ketoacidosis at onset of type 1 diabetes is a predictor of long-term glycemic control.酮症酸中毒在 1 型糖尿病发病时是长期血糖控制的预测指标。
Pediatr Diabetes. 2018 Mar;19(2):320-328. doi: 10.1111/pedi.12546. Epub 2017 Jun 1.
8
Clinical outcomes in youth beyond the first year of type 1 diabetes: Results of the Pediatric Diabetes Consortium (PDC) type 1 diabetes new onset (NeOn) study.1 型糖尿病发病后首年之外的青少年患者的临床结局:儿科糖尿病联盟(PDC)1 型糖尿病新发(NeOn)研究结果。
Pediatr Diabetes. 2017 Nov;18(7):566-573. doi: 10.1111/pedi.12459. Epub 2016 Oct 19.
9
Diabetic ketoacidosis at the onset of type 1 diabetes is associated with future HbA1c levels.1 型糖尿病发病时的糖尿病酮症酸中毒与未来的 HbA1c 水平相关。
Diabetologia. 2013 May;56(5):995-1003. doi: 10.1007/s00125-013-2850-z. Epub 2013 Feb 7.
10
Partial remission phase and metabolic control in type 1 diabetes mellitus in children and adolescents.儿童和青少年1型糖尿病的部分缓解期与代谢控制
J Pediatr Endocrinol Metab. 2001 Apr;14(4):435-41. doi: 10.1515/jpem.2001.14.4.435.

引用本文的文献

1
Why study the T1D remission phase in the pediatric population?为什么要研究儿科人群中的1型糖尿病缓解期?
J Pediatr (Rio J). 2025 Mar-Apr;101(2):117-118. doi: 10.1016/j.jped.2024.12.001. Epub 2024 Dec 20.

本文引用的文献

1
Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes.特立帕肽和新诊断 1 型糖尿病的β细胞功能。
N Engl J Med. 2023 Dec 7;389(23):2151-2161. doi: 10.1056/NEJMoa2308743. Epub 2023 Oct 18.
2
Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial.维拉帕米对新诊断的儿童 1 型糖尿病患者胰岛β细胞功能的影响:一项随机临床试验。
JAMA. 2023 Mar 28;329(12):990-999. doi: 10.1001/jama.2023.2064.
3
Residual β cell function in long-term type 1 diabetes associates with reduced incidence of hypoglycemia.长期 1 型糖尿病患者β细胞功能残留与低血糖发生率降低有关。
J Clin Invest. 2021 Feb 1;131(3). doi: 10.1172/JCI143011.
4
Influence of Age on Partial Clinical Remission among Children with Newly Diagnosed Type 1 Diabetes.年龄对新发 1 型糖尿病患儿部分临床缓解的影响。
Int J Environ Res Public Health. 2020 Jul 3;17(13):4801. doi: 10.3390/ijerph17134801.
5
The remission phase in type 1 diabetes: Changing epidemiology, definitions, and emerging immuno-metabolic mechanisms.1 型糖尿病缓解期:不断变化的流行病学、定义和新出现的免疫代谢机制。
Diabetes Metab Res Rev. 2020 Feb;36(2):e3207. doi: 10.1002/dmrr.3207. Epub 2019 Aug 13.
6
Individual and diabetes presentation characteristics associated with partial remission status in children and adults evaluated up to 12 months following diagnosis of type 1 diabetes: An ADDRESS-2 (After Diagnosis Diabetes Research Support System-2) study analysis.在诊断为 1 型糖尿病后长达 12 个月的时间内,评估儿童和成人部分缓解状态与个体和糖尿病表现特征的关系:ADDRESS-2(诊断后糖尿病研究支持系统-2)研究分析。
Diabetes Res Clin Pract. 2019 Sep;155:107789. doi: 10.1016/j.diabres.2019.107789. Epub 2019 Jul 19.
7
Remission phase in children diagnosed with type 1 diabetes in years 2012 to 2013 in Silesia, Poland: An observational study.波兰西里西亚地区 2012 年至 2013 年诊断为 1 型糖尿病的儿童缓解期:一项观察性研究。
Pediatr Diabetes. 2019 May;20(3):286-292. doi: 10.1111/pedi.12824. Epub 2019 Feb 20.
8
Factors Influencing Frequency and Duration of Remission in Children and Adolescents Newly Diagnosed with Type 1 Diabetes.影响儿童和青少年新诊断为 1 型糖尿病患者缓解频率和持续时间的因素。
Med Sci Monit. 2018 Aug 28;24:5996-6001. doi: 10.12659/MSM.908450.
9
ISPAD Clinical Practice Consensus Guidelines 2018: Stages of type 1 diabetes in children and adolescents.2018年国际儿童青少年糖尿病研究学会(ISPAD)临床实践共识指南:儿童及青少年1型糖尿病分期
Pediatr Diabetes. 2018 Oct;19 Suppl 27:20-27. doi: 10.1111/pedi.12734.
10
Factors contributing to partial remission in type 1 diabetes: analysis based on the insulin dose-adjusted HbA1c in 3657 children and adolescents from Germany and Austria.1型糖尿病部分缓解的相关因素:基于德国和奥地利3657名儿童及青少年胰岛素剂量调整后的糖化血红蛋白分析
Pediatr Diabetes. 2017 Sep;18(6):428-434. doi: 10.1111/pedi.12413. Epub 2016 Jul 15.

巴西多民族样本中1型糖尿病缓解期的分析。

An analysis of the remission phase in type 1 diabetes within a multiethnic Brazilian sample.

作者信息

Ramos Maria E N, Leão Isabella S, Vezzani Joana R D, Campos Ludmila N R, Luescher Jorge L, Berardo Renata S, Zajdenverg Lenita, Rodacki Melanie

机构信息

Universidade Federal do Rio de Janeiro, Faculdade de Medicina, Rio de Janeiro, RJ, Brazil.

Universidade Federal do Rio de Janeiro, Departamento de Medicina Interna, Rio de Janeiro, RJ, Brazil.

出版信息

J Pediatr (Rio J). 2025 Mar-Apr;101(2):167-171. doi: 10.1016/j.jped.2024.09.005. Epub 2024 Nov 4.

DOI:10.1016/j.jped.2024.09.005
PMID:39510129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11889658/
Abstract

OBJECTIVE

To assess the frequency and potential influencing factors of the remission phase (RP) in Type 1 Diabetes (T1D) as well as the associations between various criteria used for its definition.

METHODS

This was a retrospective cohort study based on data collected from medical records. Three criteria were used to evaluate RP: (1) Glycated hemoglobin (HbA1c) < 7.5 % with an insulin dose < 0.5 U/Kg/day, (2) HbA1c < 7 % with an insulin dose < 0.5 U/Kg/day, and (3) Insulin Dose Adjusted A1c (IDAA1c) ≤ 9, calculated as IDAA1c = HbA1c (%) + [4 x insulin dose (U/Kg/day)]. Statistical analyses included the Mann-Whitney U Test, Chi-Square Test, and Spearman Correlation.

RESULTS

The sample consisted of 144 T1D patients, with a mean age of 26.22 ± 8.30 years and a mean age of onset of 13.30 ± 8.50 years. Of these, 52.9 % were female, 60.3 % were Caucasoid, and 31 % experienced diabetic ketoacidosis (DKA) at disease onset. One year after diagnosis, the occurrence of RP ranged from 27.2 % to 46.8 %, depending on the criteria used. Three patients experienced RP even after seven years, according to criterion 3. No association was found between RP and age, DKA, or pubertal status at onset. The three RP criteria were highly associated with each other (p < 0.001).

CONCLUSION

A significant proportion of patients in this sample experienced RP within 12 months of diagnosis. The three criteria for defining RP were strongly associated, indicating their reliability in both clinical and research contexts.

摘要

目的

评估1型糖尿病(T1D)缓解期(RP)的发生频率及潜在影响因素,以及用于定义缓解期的各种标准之间的关联。

方法

这是一项基于病历收集数据的回顾性队列研究。采用三个标准评估缓解期:(1)糖化血红蛋白(HbA1c)<7.5%且胰岛素剂量<0.5U/Kg/天;(2)HbA1c<7%且胰岛素剂量<0.5U/Kg/天;(3)胰岛素剂量调整糖化血红蛋白(IDAA1c)≤9,计算方法为IDAA1c = HbA1c(%)+[4×胰岛素剂量(U/Kg/天)]。统计分析包括曼-惠特尼U检验、卡方检验和斯皮尔曼相关性分析。

结果

样本包括144例T1D患者,平均年龄26.22±8.30岁,平均发病年龄13.30±8.50岁。其中,52.9%为女性,60.3%为白种人,31%在疾病发作时经历过糖尿病酮症酸中毒(DKA)。诊断后一年,根据所使用的标准,缓解期的发生率在27.2%至46.8%之间。根据标准3,三名患者甚至在七年之后仍处于缓解期。未发现缓解期与发病时的年龄、DKA或青春期状态之间存在关联。三个缓解期标准彼此高度相关(p<0.001)。

结论

该样本中有很大比例的患者在诊断后12个月内经历了缓解期。定义缓解期的三个标准密切相关,表明它们在临床和研究背景下均具有可靠性。